Recursion Pharmaceuticals, Inc.

Rachunek Zysków i Strat





index 0 1 2 3 4 5
Rok finansowy 2019 2020 2021 2022 2023 2024
Przychód (mln) 2 3 10 40 45 59
Przychód Δ r/r 0.0% 99.5% 193.0% 296.8% 12.3% 32.0%
Marża brutto -2577.3% -1755.2% 9.0% -21.7% -14.6% 23.1%
EBIT (mln) -62 -85 -183 -246 -350 -479
EBIT Δ r/r 0.0% 35.5% 116.0% 34.4% 42.5% 36.8%
EBIT (%) -3649.4% -2479.2% -1827.8% -619.3% -785.3% -814.1%
Koszty finansowe (mln) 1 1 3 0 0 2
EBITDA (mln) -58 -80 -183 -246 -318 -427
EBITDA(%) -3401.5% -2353.4% -1827.8% -619.3% -712.5% -725.2%
Podatek (mln) 1 1 -8 -0 -4 -1
Zysk Netto (mln) -63 -88 -178 -239 -328 -464
Zysk netto Δ r/r 0.0% 40.6% 102.6% 34.5% 37.0% 41.3%
Zysk netto (%) -3654.3% -2574.9% -1780.7% -603.4% -736.0% -788.0%
EPS -0.38 -0.53 -1.05 -1.36 -1.58 -1.69
EPS (rozwodnione) -0.38 -0.53 -1.05 -1.36 -1.58 -1.69
Ilośc akcji (mln) 166 166 170 176 208 274
Ważona ilośc akcji (mln) 166 166 170 176 208 274
Waluta USD USD USD USD USD USD